fatty liver disease and semaglutide quietly raises your heart risk, now there is data showing Ozempic may be hitting both problems at once. A new analysis of the SELECT trial looked specifically at Semaglutide treats MASH liver disease

Based on the current biopharmaceutical landscape in early 2026, Viking Therapeutics (VKTX) remains one of the most attractive bolt-on acquisition targets for large-cap pharma companies looking to secure a foothold in the $100 billion obesity market

Patients should maintain all scheduled appointments and laboratory tests to ensure their body's response to the medication is properly tracked [14]

Either the concentration is different or the chart source uses a different concentration assumption

But our healthspan is how long we live healthily , or how long we remain not just alive, but in good health

The direct regulation of GLP-1 on insulin expression is significant for type 2 diabetes (T2D) patients with simple glucose tolerance but normal insulin secretion ( 2 Peptide-based GLP-1 derivatives and small molecule compounds of GLP-1RA There are two main categories of GLP-1 receptor agonists, small molecule compounds and peptide-based GLP-1 derivatives as shown in Figure 1 , including exenatide, liraglutide, dulaglutide, etc